UGT1A1 and hypertensive disorder: To our knowledge, this is the first study in primary human hepatocytes to evaluate the impact of PRH on UGT mRNA levels and protein concentrations, and the glucuronidation of labetalol, a UGT1A1 and UGT2B7 substrate commonly prescribed to treat hypertensive disorders of pregnancy.